Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Amortization - Intangibles (2021 - 2023)

Historic Amortization - Intangibles for Dexcom (DXCM) over the last 3 years, with Q3 2023 value amounting to $1.7 million.

  • Dexcom's Amortization - Intangibles fell 555.56% to $1.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $7.0 million, marking a year-over-year decrease of 140.85%. This contributed to the annual value of $7.5 million for FY2022, which is 10270.27% up from last year.
  • As of Q3 2023, Dexcom's Amortization - Intangibles stood at $1.7 million, which was down 555.56% from $1.7 million recorded in Q2 2023.
  • In the past 5 years, Dexcom's Amortization - Intangibles registered a high of $2.0 million during Q1 2022, and its lowest value of $500000.0 during Q2 2021.
  • Over the past 3 years, Dexcom's median Amortization - Intangibles value was $1.8 million (recorded in 2022), while the average stood at $1.6 million.
  • As far as peak fluctuations go, Dexcom's Amortization - Intangibles skyrocketed by 28000.0% in 2022, and later crashed by 1052.63% in 2023.
  • Over the past 3 years, Dexcom's Amortization - Intangibles (Quarter) stood at $1.4 million in 2021, then increased by 28.57% to $1.8 million in 2022, then decreased by 5.56% to $1.7 million in 2023.
  • Its last three reported values are $1.7 million in Q3 2023, $1.7 million for Q2 2023, and $1.8 million during Q1 2023.